In Treatment of Overactive bladder (OAB) symptoms DERITAS 15 MG TABLET helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
It is not known whether it is safe to consume alcohol with DERITAS 15 MG TABLET. Please consult your doctor.
DERITAS 15 MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
DERITAS 15 MG TABLET is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
DERITAS 15 MG TABLET may cause side effects which could affect your ability to drive. DERITAS 15 MG TABLET may cause effects such as dizziness, blurred vision, trouble sleeping or drowsiness. This may affect your driving ability.
DERITAS 15 MG TABLET is safe to use in patients with kidney disease. No dose adjustment of DERITAS 15 MG TABLET is recommended. However, inform your doctor if you have any underlying kidney disease.
DERITAS 15 MG TABLET should be used with caution in patients with severe liver disease. Dose adjustment of DERITAS 15 MG TABLET may be needed. Please consult your doctor.
If you miss a dose of DERITAS 15 MG TABLET, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Dr Reddy's Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ajanta Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)